Jorge Conde
InvestorGeneral Partner, a16z at Andreessen Horowitz Β· Board director at Earli Β· Board director at Camp4 Therapeutics Corp
Menlo Park, California
Writes $1M β $100M checks Β· typically $10M
About
Jorge Conde co-founded a synthetic biology company with genomics pioneer George Church at Harvard before entering venture capital and regularly hosts podcasts interviewing scientists and CEOs, bridging academia and entrepreneurship.
ContactΒ· self-published, not guessed
Invests in
AI & Machine LearningBiotechConsumerCrypto & Web3Defense Tech
Board director at Earli
Intro paths
In turn, Jorge can intro founders to Earli's investors below.
Earli's investors Β· 6
Co-founders at Earli

Board director at Camp4 Therapeutics Corp
Intro paths
In turn, Jorge can intro founders to Camp4 Therapeutics Corp's investors below.
Experience
- Andreessen HorowitzGeneral Partnercurrent2017 β presentSilicon Valley
- Vicinitas TherapeuticsBoard Membercurrent2022 β present
- Cartography BiosciencesBoard Membercurrent2022 β present
- Dyno TherapeuticsBoard Membercurrent2021 β present
- Komodo HealthBoard Membercurrent2020 β present
- OctantBoard Membercurrent2019 β present
- AsimovBoard Membercurrent2019 β present
- Earli Inc.Board Membercurrent2018 β present
- IDRxBoard Member2022 β 2025
- Tome BiosciencesBoard Member2021 β 2024
- CAMP4 TherapeuticsBoard Member2018 β 2024
- EQRxBoard Member2020 β 2023
- Aria PharmaceuticalsBoard Member2019 β 2023
- Tmunity Therapeutics IncorporatedBoard Member2019 β 2023
- Syros PharmaceuticalsChief Strategy Officer | Chief Financial Officer | Chief Product Officer2014 β 2017Greater Boston Area
- Knome Inc.Co-Founder and CEO | Board of Directors2007 β 2014Greater Boston Area
- MedImmuneMarketing & Operations Manager2006 β 2007Washington D.C. Metro Area
- Biotechnology and genomics companiesIndependent Consultant2003 β 2006Greater Boston Area
- Flagship VenturesLife Sciences Summer Associate2005Greater Boston Area
- Morgan StanleyBiotechnology Investment Banking2000 β 2003Greater New York City Area
Skills & more
+10 more
Data MiningTechnology TransferComputational BiologyProduct ManagementDue DiligenceGeneticsCorporate DevelopmentLife SciencesBusiness StrategyRLanguages English Β· Spanish
From Jorge's professional profile.
Deals Β· 2
EarliBoard seat
via Andreessen Horowitz Β· filed Jan 2021 Β· $40M raise
Camp4 Therapeutics CorpBoard seat
via Andreessen Horowitz Β· filed Sep 2018 Β· $34.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Andreessen Horowitz
Network1
Investors connected to Jorge in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Jorge Conde?
- Jorge Conde co-founded a synthetic biology company with genomics pioneer George Church at Harvard before entering venture capital and regularly hosts podcasts interviewing scientists and CEOs, bridging academia and entrepreneurship.
- Where does Jorge Conde work?
- Jorge Conde is General Partner, a16z at Andreessen Horowitz and Board director at Earli and Board director at Camp4 Therapeutics Corp.
- What does Jorge Conde invest in?
- Jorge Conde invests in AI & Machine Learning, Biotech, Consumer, Crypto & Web3, Defense Tech.
- What check size does Jorge Conde write?
- Jorge Conde typically writes checks of $1M β $100M.
- What boards does Jorge Conde sit on?
- Jorge Conde holds tracked board seats at Camp4 Therapeutics Corp, Earli.
- Where did Jorge Conde go to school?
- Jorge Conde studied at Harvard Business School (Master of Business Administration (MBA)); Massachusetts Institute of Technology (Master of Science (MS), Biomedical Enterprise Program); The Johns Hopkins University (Bachelor of Arts (BA), Biology).
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Massachusetts Institute of Technology1,387
+ 1,381 more
Also attended The Johns Hopkins University262
+ 256 more
Shared employers
Also worked at Komodo Health7
+ 1 more

















































